Our People
|
|||
jfassberg@troutgroup.com |
Mr. Fassberg is the Founder and CEO of The Trout Group. He has worked in the life sciences industry for fifteen years and been an advisor to senior management of over 100 companies, public and private. Prior to founding Trout in 1995, Jonathan was a sell-side analyst at a healthcare focused investment bank. Before his career on Wall Street, Jonathan spent four years at DuPont Pharma in various sales and marketing positions. He holds a Bachelor of Science in Biology and Chemistry from The University of North Carolina – Chapel Hill and a Masters of Business Administration in Finance from New York University’s Stern School of Business. He also holds Series 7, 24 and 63 securities licenses. |
||
|
|||
lstern@troutgroup.com |
Mr. Stern has a broad array of experience in investor relations, management consulting and finance. Since joining Trout in 1999, he has worked with numerous health sciences companies to develop and implement their investor positioning strategies, helped companies with capital raising strategies and advised senior management on general company strategy. Lee has presented at industry conferences, including the Strategic Investor Relations Conference. His responsibilities also include daily operations of the firm. He holds a Bachelor of Science in Quantitative Economics from Tufts University and is a Chartered Financial Analyst (CFA). He also holds Series 7, 24 and 63 securities licenses. He is a member of the NY Society of Security Analysts (NYSSA) and the CFA Institute. He also plays drums for a NY-based rock and roll band. |
||
|
|||
clabaree@troutgroup.com |
Ms. Labaree joined the firm in 2003 with more than 10 years experience in healthcare investor and public relations, corporate and marketing communications and product marketing. She manages Trout's investor relations team from the Boston area office. Christine came to Trout from Biocompatibles International plc, a biopolymer drug delivery company where she was corporate communications director and managed US investor relations. She was previously North American marketing manager for a division of the company. In prior positions, Christine was healthcare group manager at a Boston public relations firm and led media and government relations efforts for the American Cancer Society in New Hampshire. Christine holds a Bachelor of Arts from the University of Notre Dame and completed a 1-year graduate program in business administration at Harvard University. She also holds holds Series 7 and 63 securities licenses. In her spare time, Christine enjoys exploring the more rural parts of New England on foot, horseback or motorcycle. |
||
|
|||
mlevitan@troutgroup.com |
Mr. Levitan joined the firm in 2007 to expand the firm’s capital-raising, M&A and strategic advisory services efforts provided through Trout Capital LLC. Michael has 14 years experience in healthcare investment banking and corporate development, principally focused on the biotechnology, pharmaceuticals, life sciences and life science IT sectors. Michael has executed a broad range of healthcare transactions totaling over $3 billion in value. He has senior-level experience with boutique investment banks and with Bear Stearns in New York. He commenced his investment banking career at Lehman Brothers in 1996. Before that, he worked at Eli Lilly in medical device and pharmaceuticals business development.
Michael earned an MBA in Finance and Marketing from the University of Chicago Graduate School of Business, and a Bachelor of Engineering degree in electrical and computer engineering from McGill University . He also holds Series 7 and 63 securities licenses. Michael enjoys skiing, golf, and spending time with his wife and son. |
||
|
|||
blewis@troutgroup.com |
Mr. Lewis joined the firm in 1998 where he has advised public and private biotech companies, both domestic and abroad, in a variety of capacities. He has developed a network within the biotechnology venture community specifically to support the IR needs of private companies. His experience includes work within finance, consulting, research and life sciences and M&A consulting services. He has been involved in the start-up phase of several companies, and has had first-hand experience in business development and licensing. He holds a Bachelor of Science in Cardiopulmonary Science with a minor in Engineering and Small Business Management from Northeastern University and a Masters of Business Administration in Finance at New York University's Stern School of Business. He also holds Series 7, 24 and 63 securities licenses. He is a member of the New York Biotechnology Association (NYBA) and the Stern Pharmaceutical and Healthcare Association (SPHA). |
||
|
|||||||
|
|||
mbooth@troutgroup.com |
Dr. Booth joined the Trout Group in 2007 having spent nine years at investment banks serving the life sciences sector. The last seven years were spent as an equity research analyst covering pan-European biotechnology stocks at UBS, Bank of America and Canaccord Adams. Mike runs Trout's European office* from London. |
||
|
|||
iclements@troutgroup.com |
Dr. Clements has more than 10 years experience in life science communications. His background includes investor and public relations, corporate and marketing communications, and product marketing. Ian manages Trout’s Bay area office. |
||
|
|||
tryan@troutgroup.com |
Mr. Ryan joined the firm in 2003 and has been active in the investment industry for twenty years. He has held senior management positions at a number of Wall Street investment firms and has broad experience in investment banking, retail and institutional sales. He was a principal of Hambrecht & Quist and a senior vice president at Lehman Brothers and Auerbach, Pollak & Richardson. Tim also previously served as the Chairman of the Board of Stryka Botanics, a company which supplies raw materials used in the manufacturing of vitamins and supplements, where he led the effort to successfully buy the Company out of Chapter 11 Bankruptcy. |
||
|
|||
tfechtner@troutgroup.com |
Mr. Fechtner joined the firm in 2001 and has been involved in a wide variety of activities at Trout. His language skills, his knowledge of the European markets, and his relationships with the European investment community have helped Trout clients expand their reach into Europe. His experience prior to joining the firm includes the sales of financial products and business communications. Thomas guides clients based outside of the United States in understanding the US biotech markets and developing their US investor marketing strategies. His role in investor relations for both domestic and international clients includes many aspects, such as investor targeting and road show outreach/logistics, implementing strategic planning, developing conference call scripts and investor audits. He also plans and advises biotechnology related investor conferences and assists in developing effective websites for clients. Thomas completed his studies at the University of Augsburg in Germany. Thomas has earned the honorary Trout title of Global Concierge. |
||
|
||||
bkorb@troutgroup.com |
Mr. Korb has structured and implemented
investor relations programs for a number of companies in the
biotech and medical device sectors since joining the firm in
2000. He has developed targeted initiatives covering ongoing
litigation, financings, partnerships, clinical trials, earnings
and data announcements. He has managed investor relations in
positive and crisis situations, dealing directly with the
institutional, analyst and retail communities. He previously
worked as an assistant director for the California Public
Interest Research Group, a non-profit environmental organization
where he headed fundraising efforts in Southern California and
attracted media coverage on target issues by drafting press
releases and organizing news conferences. |
|||
|
||||
lrigg@troutgroup.com |
Dr. Rigg joined the Trout Group in 2008 having spent nearly seven years at Goldman Sachs as an investment research analyst in the Healthcare team. Lauren spent three years working in the European Biotech team before transitioning to the European Pharmaceutical team at GS where her responsiblities included in-depth pipeline/product analysis, responding to investor requests across multiple therapeutic areas and attending medical meetings. Lauren joins Mike Booth who runs Trout's European office* in London. Prior to joining Goldman Sachs, Lauren worked as a post-doc research scientist in the Department of Pharmacology, Oxford. She holds a D.Phil (Ph.D) in Cardiac Pharmacology and a degree in Physiological Sciences from the University of Oxford. In her spare time Lauren enjoys skiing, sailing (in calm seas!) and spending time with friends and family. |
|||
|
||||
crubin@troutgroup.com |
Mr. Rubin joined Trout’s team in 2005 after co-heading the Biotechnology Capital Markets Intelligence Group at Thomson Financial, assisting over 50 life sciences companies in their understanding of Wall Street. He brings with him over six years of experience in advising life science companies on topics including shareholder targeting, capital markets transactions, message crafting and scenario analysis. His experience includes work in finance, consulting and market analysis. He has been involved with companies from pre-IPO stages to follow-on and convertible offerings. |
|||
|
||||
cyang@troutgroup.com |
Ms. Yang joined the Trout Group in 2005. Previously, she co-headed the Biotechnology Capital Markets Intelligence Group at Thomson Financial and managed a team of nine analysts and over 50 clients. She brings her investor advisory experiences with her to Trout, giving clients a broader understanding of their current shareholder base. |
|||
|
|||||||||
lglaser@troutgroup.com |
Ms. Glaser joined the firm in 2004, and is based in our San Fransisco office where she offers both on-site access to the west coast investment community as well as supporting Trout clients making the trip to the Bay area for roadshows, conferences and corporate events. Prior to Trout she spent a year travelling, and completed research in palliative care and women's health in multi-generational households at the Children's Hospital of Philadelphia. She has provided both US and Australian companies with comprehensive investor relations and strategic development programs. |
||||||||
|
|||||||||
gogawa@troutgroup.com |
Ms. Ogawa joined the firm in 2004. She brings a diverse scientific background stemming from her four years of research experience in academia and industry. She joined the firm from Medarex, Inc., a monoclonal antibody focused company, where she helped create a BCL-2 mouse for optimal monoclonal antibody production. She was previously a research associate at StemCells, Inc. where she worked in the development of neural markers as they related to monoclonal antibody and protein fragments. |
||||||||
|
|||||||||
|
|||||||||
slewis@troutgroup.com |
Mr. Lewis joined Trout in 2004. At the heart of his professional experience is client service - helping clients develop and implement strategies to achieve specific goals and measuring progress along the way. Prior to joining Trout, Seth was a Financial Consultant with Smith Barney where he developed relationships with both individuals and corporations, assisting them with portfolio management and strategic consulting. His background also includes over two years working in estate planning, advising senior citizens on issues regarding Medicare, Medicaid, prescriptions, and long term care. Seth is based in our Boston office. Seth has a Bachelor of Arts in History from Hartwick College. He also holds Series 7 and 63 securities licenses and is a Series 65 Registered Investment Advisor. Seth is known to have an uncanny knowledge of all things trivial. |
||||||||
|
|||||||||
| Laura Okpala, Associate | ||
lokpala@troutgroup.com |
Ms. Okpala joined the Trout Group in 2006 and is based in the Laura graduated from Princeton University with a Bachelor of Arts in Ecology and Evolutionary Biology with a certificate in Spanish. Her independent undergraduate thesis research at |
|
| Peter Rahmer, Associate | ||
prahmer@troutgroup.com |
Mr. Rahmer joined the Trout Group in 2007. Peter comes with a diverse academic background complimented with recent work experience as part of Thomson Financial’s Biotechnology Capital Markets Intelligence team. He has experience working with biotech companies ranging from micro-cap to large-cap and pre-clinical to marketed products. Peter has specialized in assisting in investor relations efforts encompassing market intelligence, investor targeting, and situation analysis. Peter is based in our San Francisco office. Peter holds a Bachelor of Arts in Economics from St. Lawrence University and a Masters of Business Administration with a concentration in International Business from the Rochester Institute of Technology. While obtaining his degrees Peter had the opportunity to study in China , Scotland , and Washington , DC. He enjoys traveling and all activities that keep him outdoors |
|
| David Warren, Associate | ||
dwarren@troutgroup.com |
Mr. Warren joined the Trout Group in 2007 and is based in the New York office. He comes with an economics-based understanding of the financial markets. In addition to implementing investor relations programs for clients, David will be assisting with many of the quantitative functions, such as investor targeting, charting, indexing and other financial analyses. David has prior experience from various roles focused on financial markets and alternative investing. He has spent time in both asset allocation within the investment office for the Tufts University Endowment portfolio, and private wealth management at a bulge bracket investment firm. David holds a Bachelor of Arts Degree in Economics from Tufts University. While at Tufts he co-founded an ongoing public health fundraising initiative for the Crohn's and Colitis Foundation of America. During his free time David enjoys golf, playing guitar, and is an aspiring outdoorsman. |
|
| Jessica Lloyd , Junior Associate | ||
jlloyd@troutgroup.com |
Ms. Lloyd joined The Trout Group in 2008 and is based in the New York office. Jessica is assisting in the implementation of investor relations programs for various clients. She has a wide range of experience across the public relations, publishing, event planning, and financial industries. Prior to Trout, she worked in the Corporate Marketing and Events division at Bear Stearns and in particular, liaised with numerous healthcare and biotechnology companies while planning and coordinating the 2007 Healthcare Conference. Jessica graduated with distinction from Emory University’s Goizueta Business School with a Bachelor of Business Administration in Marketing and Organization & Management. |
|
|
||||
cgittens@troutgroup.com |
Ms. Gittens joined the firm in 2000. As
Office Manager, she is responsible for the bookkeeping, human
resources and general office services of the firm. She is also
involved in event coordination and materials development. |
|||
|
|||
tgittens@troutgroup.com |
Ms. Gittens joined the firm in 2002. With over 5 years of experience in the biotechnology sector, she assists in coordinating and executing investor relations activities, including outreach programs, roadshows and investor conferences. She also compiles financial analysis reports for various clients. |
||
|
|||
ggordon@troutgroup.com |
Mr. Gordon has rejoined the Trout Group as Director of Information Technology, after 7 years as the firm’s IT consultant, providing comprehensive information technology services. Prior to this, Geoff was the Vice President of US Systems for DBRS, Inc., a NRSRO accredited bond rating agency located in New York City. There, he was responsible for the New York, Chicago, Virginia, and Texas offices, totaling 88 employees. Geoff has significant Microsoft Windows expertise and experience in the financial and legal sectors. He has worked externally for many smaller NY businesses on networking, desktop, and helpdesk projects. Geoff holds a Bachelor of Arts degree from Tufts University and is a Microsoft Certified Professional. He has also completed training in Windows XP, Active Directory, and Windows 2000 Server. In his spare time, he runs a small computer consulting company and is an authorized reseller for Dell Computers. |
||
|
|||
cwong@troutgroup.com |
Mr. Wong joined the firm in 2007. As our Controller, he is responsible for the daily operation of the accounting department as well as the financial reporting functions. Chris has over 15 years of accounting experience in the public relations and mutual fund industries. Previously, Chris worked at Neuberger Berman as a senior mutual fund accountant. Chris is a Notary Public in New York State. Chris is a graduate of Baruch College with a Bachelor in Business Administration. |
||
|
|||
frontdesk@troutgroup.com |
Ms. Edwards joined the firm in 2007. She is currently a sophomore majoring in Accounting (CPA) at Medgar Evers College and plans to graduate in 2009.
|
||
| *Trout Group International, LLC | |||